Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT05728697)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT05728697 Sponsor: Brigham and Women's Hospital Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05728697 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You are already scheduled to have an endoscopic ultrasound (a procedure using a camera and sound waves to look inside the body) and a liver biopsy (a procedure where a small sample of liver tissue is taken) as part of your normal medical care
You have been suspected of having or already diagnosed with non-alcoholic fatty liver disease (a condition where fat builds up in the liver, not caused by alcohol) before the procedure
Your body mass index (BMI), which is a measure of body weight relative to height, is 25 or above

Who may not be able to join:

Your liver biopsy did not provide enough tissue to be properly tested or analyzed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marvin Ryou, MD, Brigham and Women's Hospital

Phone: 6177325500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05728697

Sponsor: Brigham and Women's Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: 6177325500

More information: https://clinicaltrials.gov/study/NCT05728697

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You are already scheduled to have an endoscopic ultrasound (a procedure using a camera and sound waves to look inside the body) and a liver biopsy (a procedure where a small sample of liver tissue is taken) as part of your normal medical care
You have been suspected of having or already diagnosed with non-alcoholic fatty liver disease (a condition where fat builds up in the liver, not caused by alcohol) before the procedure
Your body mass index (BMI), which is a measure of body weight relative to height, is 25 or above

Who may not be able to join:

Your liver biopsy did not provide enough tissue to be properly tested or analyzed

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Brigham and Women's Hospital

Registry

ClinicalTrials.gov

Start date

1 June 2021

Est. completion

1 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Accuracy of EUS-SWE in reference to the gold standard liver biopsy; Optimal stiffness cutoffs for EUS-SWE based on AUROC analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov